A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Neurosciences Bookmark and Share

Neurosciences

Study of the nervous system has a long tradition at City of Hope, which was one of the first institutions in North America to establish a neurobiology research department.

The Department of Neurosciences offers a multidisciplinary research and training environment in neurobiology, with a particular focus on developmental aspects of the nervous system. Research in the department encompasses molecular and cellular neurobiology, genetics and neurophysiology, with ongoing studies in neurogenesis and synaptogenesis, migration and specification, degeneration and embryonic stem cell differentiation.

Researchers in the department collaborate with colleagues in other basic science departments and divisions as well as clinical researchers in neuro-oncology programs, focusing on cancer immunotherapy and neurosurgery.
 
Laboratory Research
The Department of Neurosciences spans a broad range of research interests; grouped into three major categories:

I.Several investigators are interested in the earliest periods of neurogenesis and lineage commitment, and are examining stem and progenitor cells in developing and mature brain:
 
  • Qiang Lu, Ph.D. – Neural Progenitor/Stem Cells in Brain Development
    Dr. Lu’s research is concerned with intercellular signaling by ephrins and Eph receptors and their regulation of neuronal birth and migration during early development of the cerebral cortex.
 
  • Yanhong Shi, Ph.D. – Nuclear Receptors in Neural Stem Cells and Adult Neurogenesis
    Dr. Shi is studying the nuclear receptors that control generation and differentiation of neural lineage stem cells in the adult nervous system.
 
  • Michael Barish, Ph.D. – Neurobiology of Development
    Dr. Barish is investigating early electrical activity in the developing hippocampus and cortex and its relationship to neural birth, migration and maturation.
     
  • Karen S. Aboody, M.D.Translational Research
    Dr. Aboody oversees a translational research laboratory focused on neural stem cells (NSCs) as a platform for targeted delivery of therapeutic agents to invasive and metastatic solid tumors.

II.Several faculty have research foci in neural specification, processes that impart individuality to developing neurons, and in the functioning of mature neurons.
 
  • Paul Salvaterra, Ph.D. – Molecular Neurobiology
    Dr. Salvaterra’s research is focused on the regulation of transmitter phenotype, how gene expression is coordinated to allow synthesis and release of individual neurotransmitters.
 
  • Toshifumi Tomoda, Ph.D. – Axonal Trafficking / Neurodegeneration
    Dr. Tomoda is interested in membrane transport and cycling, and its role in axon and dendrite growth, differentiation of synapses, and stress-induced autophagy.
 
  • Kazuo Ikeda, Ph.D. – Neurophysiology
    Dr. Ikeda studies the mechanisms of synaptic transmission and plasticity, focusing on endocytosis of synaptic vesicle membrane from presynaptic terminals and processes of recovery from vesicle depletion as a consequence of activity.

III.Several faculty members also have projects that relate their fundamental research interests to mechanisms underlying diseases of the human nervous system.
 
  • Dr. Salvaterra is developing Drosophila models for Alzheimer’s and other degenerative diseases.
     
  • Dr. Lu is examining how alteration in the neural stem cell decision to proliferate or differentiate controlled by ephrin/Eph receptor signaling may be involved in the earliest stages of tumorigenesis.
     
  • Dr. Tomoda is investigating possible connections between genes involved in membrane cycling and autophagy, and several diseases including Huntington’s and schizophrenia.
     
  • Dr. Barish, in collaboration with Karen Aboody, M.D. , (Hematology/HCT) and Carlotta Glackin, Ph.D. , is examining the molecular mechanisms of neural progenitor cell migration to glioma and tumors outside the brain, and targeting of these tumors with genetically-modified therapeutics using immortalized neural progenitor cells.
     
  • Dr. Glackin and her laboratory are investigating the molecular mechanisms of a bHLH transcription factor, TWIST, in regulating cellular invasiveness. Understanding these mechanisms has allowed her laboratory to develop novel genetically-modified therapeutics that interferes with TWIST function to competitively inhibit cellular invasion of tumor cells.

Neurosciences Faculty

Neurosciences

Neurosciences

Study of the nervous system has a long tradition at City of Hope, which was one of the first institutions in North America to establish a neurobiology research department.

The Department of Neurosciences offers a multidisciplinary research and training environment in neurobiology, with a particular focus on developmental aspects of the nervous system. Research in the department encompasses molecular and cellular neurobiology, genetics and neurophysiology, with ongoing studies in neurogenesis and synaptogenesis, migration and specification, degeneration and embryonic stem cell differentiation.

Researchers in the department collaborate with colleagues in other basic science departments and divisions as well as clinical researchers in neuro-oncology programs, focusing on cancer immunotherapy and neurosurgery.
 
Laboratory Research
The Department of Neurosciences spans a broad range of research interests; grouped into three major categories:

I.Several investigators are interested in the earliest periods of neurogenesis and lineage commitment, and are examining stem and progenitor cells in developing and mature brain:
 
  • Qiang Lu, Ph.D. – Neural Progenitor/Stem Cells in Brain Development
    Dr. Lu’s research is concerned with intercellular signaling by ephrins and Eph receptors and their regulation of neuronal birth and migration during early development of the cerebral cortex.
 
  • Yanhong Shi, Ph.D. – Nuclear Receptors in Neural Stem Cells and Adult Neurogenesis
    Dr. Shi is studying the nuclear receptors that control generation and differentiation of neural lineage stem cells in the adult nervous system.
 
  • Michael Barish, Ph.D. – Neurobiology of Development
    Dr. Barish is investigating early electrical activity in the developing hippocampus and cortex and its relationship to neural birth, migration and maturation.
     
  • Karen S. Aboody, M.D.Translational Research
    Dr. Aboody oversees a translational research laboratory focused on neural stem cells (NSCs) as a platform for targeted delivery of therapeutic agents to invasive and metastatic solid tumors.

II.Several faculty have research foci in neural specification, processes that impart individuality to developing neurons, and in the functioning of mature neurons.
 
  • Paul Salvaterra, Ph.D. – Molecular Neurobiology
    Dr. Salvaterra’s research is focused on the regulation of transmitter phenotype, how gene expression is coordinated to allow synthesis and release of individual neurotransmitters.
 
  • Toshifumi Tomoda, Ph.D. – Axonal Trafficking / Neurodegeneration
    Dr. Tomoda is interested in membrane transport and cycling, and its role in axon and dendrite growth, differentiation of synapses, and stress-induced autophagy.
 
  • Kazuo Ikeda, Ph.D. – Neurophysiology
    Dr. Ikeda studies the mechanisms of synaptic transmission and plasticity, focusing on endocytosis of synaptic vesicle membrane from presynaptic terminals and processes of recovery from vesicle depletion as a consequence of activity.

III.Several faculty members also have projects that relate their fundamental research interests to mechanisms underlying diseases of the human nervous system.
 
  • Dr. Salvaterra is developing Drosophila models for Alzheimer’s and other degenerative diseases.
     
  • Dr. Lu is examining how alteration in the neural stem cell decision to proliferate or differentiate controlled by ephrin/Eph receptor signaling may be involved in the earliest stages of tumorigenesis.
     
  • Dr. Tomoda is investigating possible connections between genes involved in membrane cycling and autophagy, and several diseases including Huntington’s and schizophrenia.
     
  • Dr. Barish, in collaboration with Karen Aboody, M.D. , (Hematology/HCT) and Carlotta Glackin, Ph.D. , is examining the molecular mechanisms of neural progenitor cell migration to glioma and tumors outside the brain, and targeting of these tumors with genetically-modified therapeutics using immortalized neural progenitor cells.
     
  • Dr. Glackin and her laboratory are investigating the molecular mechanisms of a bHLH transcription factor, TWIST, in regulating cellular invasiveness. Understanding these mechanisms has allowed her laboratory to develop novel genetically-modified therapeutics that interferes with TWIST function to competitively inhibit cellular invasion of tumor cells.

Neurosciences Faculty

Neurosciences Faculty

Overview
Beckman Research Institute of City of Hope is responsible for fundamentally expanding the world’s understanding of how biology affects diseases such as cancer, HIV/AIDS and diabetes.
 
 
Research Departments/Divisions

City of Hope is a leader in translational research - integrating basic science, clinical research and patient care.
 

Research Shared Services

City of Hope embodies the spirit of scientific collaboration by sharing services and core facilities with colleagues here and around the world.
 

Our Scientists

Our research laboratories are led by the best and brightest minds in scientific research.
 

City of Hope’s Irell & Manella Graduate School of Biological Sciences equips students with the skills and strategies to transform the future of modern medicine.
Develop new therapies, diagnostics and preventions in the fight against cancer and other life-threatening diseases.
 


NEWS & UPDATES
  • Think twice before tossing out those hormone replacement pills. Although a new Lancet study suggests that hormone replacement therapy could increase a woman’s risk of ovarian cancer, a City of Hope expert urges women to keep this news in perspective. Hormone replacement therapy is prescribed to help allev...
  • Don’t know what to take, or send, that friend of yours in the hospital? Try a paper plate — filled not with cookies or sweets, but an image of yourself. Ilana Massi, currently undergoing treatment at City of Hope for acute myeloid leukemia, can vouch for the power of such a gift. She’s surrounded herself [̷...
  • With precision medicine now a national priority, City of Hope has joined a novel research partnership designed to further understanding of cancer at the molecular level, ultimately leading to more targeted cancer treatments. The Oncology Research Information Exchange Network, or ORIEN, is the world’s larg...
  • The spinal cord is an integral part of the human body, connecting the brain to everything else. So when a tumor grows on the spine, any messages that the brain tries to send to the rest of the body are interrupted, making everyday tasks — such as walking — more difficult. This year an estimated 22,850 […]
  • Each year, thousands of patients with hematologic malignancies undergo allogeneic stem cell transplantation (that is, they receive a donor’s stem cells), offering them a chance at cure. Graft-versus-host disease is a potentially deadly complication of this therapy and occurs in approximately 25 to 60 perc...
  • Bertram Yuh, M.D., assistant clinical professor in the Division of Urology and Urologic Oncology at City of Hope, offers his perspective on the benefits of surgery for aggressive prostate cancer. For men walking out of the doctor’s office after a diagnosis of cancer, the reality can hit like a ton of bricks. Th...
  • Although many Hispanic women face a high risk of mutations in the BRCA1 and BRCA2 genes – increasing their risk of breast and ovarian cancer – screenings for these mutations can be prohibitively expensive in Mexico and other Latin American countries. As a result, too many women don’t get the information t...
  • Providing lung cancer treatments to patients when their cancer is at its earliest and most treatable stages will now be a more attainable goal: Medicare has agreed to cover lung cancer screening for those beneficiaries who meet the requirements. The only proven way to detect lung cancer early enough to save liv...
  • At City of Hope, innovative scientific research, important clinical studies and vital construction projects are all powered by philanthropy. Generous supporters fuel a powerful and diverse range of progress in science and medicine, enabling researchers and clinicians to improve cancer treatments and create cure...
  • Trevor Hoffman was only 21 when he was diagnosed with a rare form of cancer, but not even cancer could keep him off his motorcycles. (He has one for racing, and a couple just for fun.) Now a cancer survivor, Hoffman, who lives in La Verne, California, wrapped up his treatment Jan. 19 – just one day […]
  • Valentine’s Day is synonymous with dinner reservations, red roses, heart-shaped boxes of chocolates and — more often than not — unrealistically high expectations. Managing those expectations is great advice for all couples on Feb. 14 — and is especially important for couples confronting a cancer diagnosis. Focu...
  • With measles, what starts at a theme park in California definitely doesn’t stay at a theme park in California. Since the beginning of the current measles outbreak – traced to an initial exposure at Disneyland or Disney California Adventure during December – more than 100 people have been diagnosed with a diseas...
  • Even the most loving and secure relationship can be rattled by a life-threatening illness. When a woman is diagnosed with breast cancer, research shows one of the most important factors in helping her cope is having a supportive partner. But that partner can struggle with knowing what to say or how to best supp...
  • It’s been more than a century since Nobel Laureate Paul Ehrlich popularized the idea of a “magic bullet” targeting disease. Cancer researchers ever since have remained in hot pursuit of targeted therapies that home in on cancer cells while leaving normal cells unaffected. Linda Malkas, Ph.D., associate chair of...
  • Cancer patients face a daunting journey marked by challenges and uncertainties. For those undergoing bone marrow, or stem cell, transplantation, one complication poses a particular threat — chronic graft-versus-host disease (GVHD). Now, one researcher may have found a better way to control that threat. GVHD res...